NCT02213107 2024-11-13
Enzalutamide & Dutasteride/Finasteride as 1st Line Treatment for Patients =/> 65 Years Old With Prostate Cancer.
University of Rochester
Phase 2 Completed
University of Rochester
Roswell Park Cancer Institute
CancerCare Manitoba
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)